Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Keefe, Bruyette & Woods increased its price objective on Atlantic Union Bankshares to $40.00 from $38.00 while leaving its rating unchanged. The adjustment follows a quarterly report that topped forecasts on earnings and revenue driven by higher net interest income and fee income, even as expenses rose. Management kept 2026 guidance intact and anal…
Keefe, Bruyette & Woods raised its price target on Bar Harbor Bankshares to $35 from $34 on Monday while retaining a Market Perform rating. The move followed quarterly results that delivered $0.93 in operating earnings per share, aided by improved pre-provision net revenue, a modest expansion in net interest margin, and lower loan loss provisions. …
Saudi Arabia will reduce the scale of its flagship Neom development following a government review of its gigaprojects. Major elements of the plan, including The Line and the Trojena ski resort, are being scaled back, and the kingdom has delayed hosting the Asian Winter Games that had been set for 2029. Analysts point to a reassessment of project sc…
Firoz Tarapore, CEO of Dubai Aerospace Enterprise (DAE) Capital, told delegates at the Airline Economics conference that engine manufacturers and smaller suppliers are the principal constraints on aircraft production. He contrasted those bottlenecks with what he described as "enormous progress" at Boeing and warned of forthcoming consolidation amon…
Hungarian energy company MOL has reached a binding agreement to acquire a 56.16% stake in Serbia’s oil firm NIS from Gazprom Neft and Gazprom for a sum reported by Serbia’s president to be between €900 million and €1 billion. The transaction requires approval from the U.S. Office of Foreign Assets Control, and Russian sellers face a March 24 divest…
Billionaire investor Bill Ackman contributed $10,000 to a GoFundMe for the family of Alex Pretti, who was fatally shot by federal immigration agents in Minneapolis. The campaign had raised more than $1 million and listed Ackman’s contribution. The donation follows an earlier $10,000 gift by Ackman to a fundraiser for an immigration officer involved…
Zijin Gold has agreed to purchase Canada’s Allied Gold for about C$5.5 billion (approximately $4.02 billion), the companies said, as high gold prices bolster miner cash flows and encourage consolidation. Zijin will pay C$44 per share, representing roughly a 5.4% premium to Allied’s last closing price, and Allied’s U.S.-listed shares rose nearly 4% …
Futures tied to Canada's resource-heavy main index rose as metals prices pushed higher, helping the S&P/TSX composite finish the week at a record closing level. Investors appeared to put recent tariff threats from the U.S. to the side as gold and silver reached new peaks, while U.S. equity futures hovered near the flatline ahead of a key Federal Re…
H.C. Wainwright increased its price target for ImmunityBio Inc. (IBRX) to $10.00 from $8.00 and kept a Buy rating following favorable regulatory feedback for the company’s ANKTIVA therapy and encouraging clinical results across multiple programs. Other firms have also raised targets, and recent corporate financing flexibility adds to investor atten…
The U.S. Food and Drug Administration has authorized a single-patient expanded access Investigational New Drug application for OKYO Pharma’s topical investigational therapy urcosimod (0.05%) to treat severe neuropathic corneal pain at the University of South Florida. The small-cap biotech, which recently appointed Robert J. Dempsey as CEO, is plann…
H.C. Wainwright has maintained its Buy rating and $34.00 price target on WhiteFiber Inc (NASDAQ:WYFI) after the company disclosed preliminary fourth-quarter 2025 sales. The firm noted preliminary revenue slightly above its estimate and said it will await the full audited results before revising forecasts. The disclosure coincided with WhiteFiber's …
Saudi Arabia's equity market closed slightly higher, with the Tadawul All Share rising 0.02% to reach a one-month high. Gains were concentrated in the Energy & Utilities, Cement and Building & Construction sectors, while a larger number of individual issues fell than rose. Several names hit multi-month and all-time highs during the session. Commodi…
The South African Reserve Bank faces a close call this week between keeping its policy rate unchanged or implementing a 25 basis point reduction. UBS analysts say their view is tilted toward no change, as the central bank may prefer to wait for the March meeting after reviewing the government budget due February 12 and January inflation adjustments…
SS&C Technologies (SSNC) is the kind of stock that rarely trends on social media, yet it sits in the workflow of asset managers and financial institutions where automation and AI actually get budget. With steady cash generation, a reasonable valuation for a sticky software franchise, and a technically compressed pullback from the 2025 highs, SSNC o…
The National Bank of Hungary is widely expected to maintain its current policy rate at its forthcoming meeting, with analysts citing stronger services inflation and a larger-than-anticipated fiscal deficit as key reasons to defer cuts. UBS and Bloomberg consensus forecasts point to unchanged policy for this session, even as the central bank had sig…
Bob’s Discount Furniture, a Bain Capital-backed home furnishings chain based in Manchester, Connecticut, has filed to go public in the U.S., seeking a valuation up to $2.48 billion. The company plans to offer 19.45 million shares at $17 to $19 apiece to raise as much as $369.6 million, and expects material revenue growth for fiscal 2025 driven by c…
Bob’s Discount Furniture has submitted a registration statement to the U.S. Securities and Exchange Commission for an initial public offering of 19.45 million common shares, targeting a price range of $17.00 to $19.00 per share. Underwriters have a 30-day option to buy an additional 2.92 million shares from an existing stockholder, with proceeds fr…
MannKind Corporation's stock climbed after the U.S. Food and Drug Administration approved updated prescribing information for Afrezza, clarifying starting dose recommendations for patients switching from subcutaneous mealtime insulin - including multiple daily injections and insulin pump therapy - to inhaled insulin.
U.S. equities closed mixed on Friday as the Nasdaq extended gains while the Dow slipped, with markets stabilizing after a thaw in geopolitical risks. Attention now shifts to fourth-quarter earnings from major technology companies and the Federal Reserve's policy decision, as investors assess whether heavy AI-related investment is beginning to produ…
H.C. Wainwright raised its price target on Avino Silver & Gold (NYSE:ASM) to $12.50 from $7.40 and kept a Buy rating after reviewing the miner's 2025 production, cash position and updated valuation assumptions. The firm cited a higher price deck and a one-year roll-forward of its discounted cash flow model, with La Preciosa production expected to b…
H.C. Wainwright raised its price objective for Scholar Rock to $58 from $44 and kept a Buy recommendation after discussions with neurology key opinion leaders (KOLs) and review of the company’s launch-readiness plans for apitegromab. The firm cited positive physician feedback on recent FDA interactions, remediation efforts at manufacturing partners…
H.C. Wainwright increased its price objective on Erasca Inc (NASDAQ: ERAS) to $15.00 from $11.00 and kept a Buy rating following preliminary clinical readouts from the AURORAS-1 study of ERAS-0015, a pan-RAS agent. The firm highlighted early partial responses observed at low dose levels and cited preclinical regressions in resistant tumor models. S…
H.C. Wainwright reduced its 12-month price target on electroCore Inc. to $18 from $25 while retaining a Buy rating. The adjustment follows electroCore's Jan. 20, 2026 preliminary results showing 2025 revenue of $31.8-$32.0 million, a 26% increase year-over-year, and fourth-quarter revenue of $9.0-$9.2 million, up 30% from Q4 2024. The analyst cited…
H.C. Wainwright increased its price target on BrainsWay (BWAY) to $30.00 from $24.00 while keeping a Buy rating, citing the company’s connection to Neurolief’s newly FDA-approved ProlivRx system and a small bump in the forward earnings multiple. The firm also factors $100 million of intrinsic value for BrainsWay’s strategic stake in Neurolief. Rece…
H.C. Wainwright raised its price target on Mirum Pharmaceuticals (MIRM) to $130.00 from $102.00 and kept a Buy rating, pointing to 2026 as a critical year for the company’s lead candidate volixibat. The stock has climbed sharply over the past year and recent preliminary sales results and multiple analyst actions have reinforced optimism about Mirum…
